BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 33137090)

  • 1. Estimated health benefits, costs, and cost-effectiveness of eliminating industrial trans-fatty acids in Australia: A modelling study.
    Marklund M; Zheng M; Veerman JL; Wu JHY
    PLoS Med; 2020 Nov; 17(11):e1003407. PubMed ID: 33137090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimated health benefits, costs and cost-effectiveness of eliminating dietary industrial trans fatty acids in Kenya: cost-effectiveness analysis.
    Marklund M; Aminde LN; Wanjau MN; Huang L; Awuor C; Steele L; Cobb LK; Veerman JL; Wu JH
    BMJ Glob Health; 2023 Oct; 8(10):. PubMed ID: 37848268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modelled health benefits of a sugar-sweetened beverage tax across different socioeconomic groups in Australia: A cost-effectiveness and equity analysis.
    Lal A; Mantilla-Herrera AM; Veerman L; Backholer K; Sacks G; Moodie M; Siahpush M; Carter R; Peeters A
    PLoS Med; 2017 Jun; 14(6):e1002326. PubMed ID: 28654688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness analysis of eliminating industrial and all trans fats in England and Wales: modelling study.
    Pearson-Stuttard J; Hooton W; Critchley J; Capewell S; Collins M; Mason H; Guzman-Castillo M; O'Flaherty M
    J Public Health (Oxf); 2017 Sep; 39(3):574-582. PubMed ID: 27613767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of Trans-Fatty Acid Intake to Coronary Heart Disease Burden in Australia: A Modelling Study.
    Wu JH; Zheng M; Catterall E; Downs S; Thomas B; Veerman L; Barendregt JJ
    Nutrients; 2017 Jan; 9(1):. PubMed ID: 28106762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential of trans fats policies to reduce socioeconomic inequalities in mortality from coronary heart disease in England: cost effectiveness modelling study.
    Allen K; Pearson-Stuttard J; Hooton W; Diggle P; Capewell S; O'Flaherty M
    BMJ; 2015 Sep; 351():h4583. PubMed ID: 26374614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Potential Cost-Effectiveness and Equity Impacts of Restricting Television Advertising of Unhealthy Food and Beverages to Australian Children.
    Brown V; Ananthapavan J; Veerman L; Sacks G; Lal A; Peeters A; Backholer K; Moodie M
    Nutrients; 2018 May; 10(5):. PubMed ID: 29762517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and application of the TFA macrosimulation model: a case study of modelling the impact of trans fatty acid (TFA) elimination policies in Brazil.
    Nilson EAF; Khandpur N; da Silva Gomes F
    BMC Public Health; 2022 Nov; 22(1):2010. PubMed ID: 36324096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of financial incentives and disincentives for improving food purchases and health through the US Supplemental Nutrition Assistance Program (SNAP): A microsimulation study.
    Mozaffarian D; Liu J; Sy S; Huang Y; Rehm C; Lee Y; Wilde P; Abrahams-Gessel S; de Souza Veiga Jardim T; Gaziano T; Micha R
    PLoS Med; 2018 Oct; 15(10):e1002661. PubMed ID: 30278053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-Effectiveness of Product Reformulation in Response to the Health Star Rating Food Labelling System in Australia.
    Mantilla Herrera AM; Crino M; Erskine HE; Sacks G; Ananthapavan J; Mhurchu CN; Lee YY
    Nutrients; 2018 May; 10(5):. PubMed ID: 29757979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disability and costs of IHD attributable to the consumption of trans-fatty acids in Brazil.
    Parajára MDC; Fogal Vegi AS; Machado ÍE; Menezes MC; Verly-Jr E; Meireles AL
    Public Health Nutr; 2024 May; 27(1):e132. PubMed ID: 38726481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eliminating artificial trans fatty acids in Argentina: estimated effects on the burden of coronary heart disease and costs.
    Rubinstein A; Elorriaga N; Garay OU; Poggio R; Caporale J; Matta MG; Augustovski F; Pichon-Riviere A; Mozaffarian D
    Bull World Health Organ; 2015 Sep; 93(9):614-22. PubMed ID: 26478625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Public health economic evaluation of different European Union-level policy options aimed at reducing population dietary trans fat intake.
    Martin-Saborido C; Mouratidou T; Livaniou A; Caldeira S; Wollgast J
    Am J Clin Nutr; 2016 Nov; 104(5):1218-1226. PubMed ID: 27680991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health and Economic Impacts of the National Menu Calorie Labeling Law in the United States: A Microsimulation Study.
    Liu J; Mozaffarian D; Sy S; Lee Y; Wilde PE; Abrahams-Gessel S; Gaziano T; Micha R;
    Circ Cardiovasc Qual Outcomes; 2020 Jun; 13(6):e006313. PubMed ID: 32493057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantifying benefits of the Danish transfat ban for coronary heart disease mortality 1991-2007: Socioeconomic analysis using the IMPACTsec model.
    Bjoernsbo KS; Joensen AM; Joergensen T; Lundbye-Christensen S; Bysted A; Christensen T; Fagt S; Capewell S; O'Flaherty M
    PLoS One; 2022; 17(8):e0272744. PubMed ID: 35976852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of community-based childhood obesity prevention interventions in Australia.
    Ananthapavan J; Nguyen PK; Bowe SJ; Sacks G; Mantilla Herrera AM; Swinburn B; Brown V; Sweeney R; Lal A; Strugnell C; Moodie M
    Int J Obes (Lond); 2019 May; 43(5):1102-1112. PubMed ID: 30926947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDA Sodium Reduction Targets and the Food Industry: Are There Incentives to Reformulate? Microsimulation Cost-Effectiveness Analysis.
    Collins B; Kypridemos C; Pearson-Stuttard J; Huang Y; Bandosz P; Wilde P; Kersh R; Capewell S; Mozaffarian D; Whitsel LP; Micha R; O'Flaherty M;
    Milbank Q; 2019 Sep; 97(3):858-880. PubMed ID: 31332837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing the Price of Alcohol as an Obesity Prevention Measure: The Potential Cost-Effectiveness of Introducing a Uniform Volumetric Tax and a Minimum Floor Price on Alcohol in Australia.
    Robinson E; Nguyen P; Jiang H; Livingston M; Ananthapavan J; Lal A; Sacks G
    Nutrients; 2020 Feb; 12(3):. PubMed ID: 32110864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Modelled Population Obesity-Related Health Benefits of Reducing Consumption of Discretionary Foods in Australia.
    Lal A; Peeters A; Brown V; Nguyen P; Tran HNQ; Nguyen T; Tonmukayakul U; Sacks G; Calache H; Martin J; Moodie M; Ananthapavan J
    Nutrients; 2020 Feb; 12(3):. PubMed ID: 32121199
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.